RESUMO

OBJECTIVE: This study aimed to synthesize the existing evidence on biomarkers related to coronavirus disease 2019 (COVID-19) patients who presented neurological events. METHODS: A systematic review of observational studies (any design) following PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines and the Cochrane Collaboration recommendations was performed (PROSPERO: CRD42021266995). Searches were conducted in PubMed and Scopus (updated April 2023). The methodological quality of nonrandomized studies was assessed using the Newcastle‒Ottawa Scale (NOS). An evidence gap map was built considering the reported biomarkers and NOS results. RESULTS: Nine specific markers of glial activation and neuronal injury were mapped from 35 studies published between 2020 and 2023. A total of 2,237 adult patients were evaluated in the included studies, especially during the acute phase of COVID-19. Neurofilament light chain (NfL) and glial fibrillary acidic protein (GFAP) biomarkers were the most frequently assessed (n = 27 studies, 77%, and n = 14 studies, 40%, respectively). Although these biomarkers were found to be correlated with disease severity and worse outcomes in the acute phase in several studies (p < 0.05), they were not necessarily associated with neurological events. Overall, 12 studies (34%) were judged as having low methodological quality, 9 (26%) had moderate quality, and 9 (26%) had high quality. CONCLUSIONS: Different neurological biomarkers in neurosymptomatic COVID-19 patients were identified in observational studies. Although the evidence is still scarce and conflicting for some biomarkers, well-designed longitudinal studies should further explore the pathophysiological role of NfL, GFAP, and tau protein and their potential use for COVID-19 diagnosis and management.

Assuntos

RESUMO

BACKGROUND: Chronic venous insufficiency (CVI) is a condition related to chronic venous disease that may progress to venous leg ulceration and impair quality of life of those affected. Treatments such as physical exercise may be useful to reduce CVI symptoms. This is an update of an earlier Cochrane Review. OBJECTIVES: To evaluate the benefits and harms of physical exercise programmes for the treatment of individuals with non-ulcerated CVI. SEARCH METHODS: The Cochrane Vascular Information Specialist searched the Cochrane Vascular Specialised Register, CENTRAL, MEDLINE, Embase, and CINAHL databases and World Health Organization International Clinical Trials Registry Platform and ClinicalTrials.gov trials registers to 28 March 2022. SELECTION CRITERIA: We included randomised controlled trials (RCTs) comparing exercise programmes with no exercise in people with non-ulcerated CVI. DATA COLLECTION AND ANALYSIS: We used standard Cochrane methods. Our primary outcomes were intensity of disease signs and symptoms, ejection fraction, venous refilling time, and incidence of venous leg ulcer. Our secondary outcomes were quality of life, exercise capacity, muscle strength, incidence of surgical intervention, and ankle joint mobility. We used GRADE to assess the certainty of the evidence for each outcome. MAIN RESULTS: We included five RCTs involving 146 participants. The studies compared a physical exercise group with a control group that did not perform a structured exercise programme. The exercise protocols differed between studies. We assessed three studies to be at an overall unclear risk of bias, one study at overall high risk of bias, and one study at overall low risk of bias. We were not able to combine data in meta-analysis as studies did not report all outcomes, and different methods were used to measure and report outcomes. Two studies reported intensity of CVI disease signs and symptoms using a validated scale. There was no clear difference in signs and symptoms between groups in baseline to six months after treatment (Venous Clinical Severity Score mean difference (MD) -0.38, 95% confidence interval (CI) -3.02 to 2.26; 28 participants, 1 study; very low-certainty evidence), and we are uncertain if exercise alters the intensity of signs and symptoms eight weeks after treatment (MD -4.07, 95% CI -6.53 to -1.61; 21 participants, 1 study; very low-certainty evidence). There was no clear difference in ejection fraction between groups from baseline to six months follow-up (MD 4.88, 95% CI -1.82 to 11.58; 28 participants, 1 study; very low-certainty evidence). Three studies reported on venous refilling time. We are uncertain if there is an improvement in venous refilling time between groups for baseline to six-month changes (MD 10.70 seconds, 95% CI 8.86 to 12.54; 23 participants, 1 study; very low-certainty evidence) or baseline to eight-week change (MD 9.15 seconds, 95% CI 5.53 to 12.77 for right side; MD 7.25 seconds, 95% CI 5.23 to 9.27 for left side; 21 participants, 1 study; very low-certainty evidence). There was no clear difference in venous refilling index for baseline to six-month changes (MD 0.57 mL/min, 95% CI -0.96 to 2.10; 28 participants, 1 study; very low-certainty evidence). No included studies reported the incidence of venous leg ulcers. One study reported health-related quality of life using validated instruments (Venous Insufficiency Epidemiological and Economic Study (VEINES) and 36-item Short Form Health Survey (SF-36), physical component score (PCS) and mental component score (MCS)). We are uncertain if exercise alters baseline to six-month changes in health-related quality of life between groups (VEINES-QOL: MD 4.60, 95% CI 0.78 to 8.42; SF-36 PCS: MD 5.40, 95% CI 0.63 to 10.17; SF-36 MCS: MD 0.40, 95% CI -3.85 to 4.65; 40 participants, 1 study; all very low-certainty evidence). Another study used the Chronic Venous Disease Quality of Life Questionnaire (CIVIQ-20), and we are uncertain if exercise alters baseline to eight-week changes in health-related quality of life between groups (MD 39.36, 95% CI 30.18 to 48.54; 21 participants, 1 study; very low-certainty evidence). One study reported no differences between groups without presenting data. There was no clear difference between groups in exercise capacity measured as time on treadmill (baseline to six-month changes) (MD -0.53 minutes, 95% CI -5.25 to 4.19; 35 participants, 1 study; very low-certainty evidence). We are uncertain if exercise improves exercise capacity as assessed by the 6-minute walking test (MD 77.74 metres, 95% CI 58.93 to 96.55; 21 participants, 1 study; very low-certainty evidence). Muscle strength was measured using dynamometry or using heel lifts counts. We are uncertain if exercise increases peak torque/body weight (120 revolutions per minute) (changes from baseline to six months MD 3.10 ft-lb, 95% CI 0.98 to 5.22; 29 participants, 1 study; very low-certainty evidence). There was no clear difference between groups in baseline to eight-week change in strength measured by a hand dynamometer (MD 12.24 lb, 95% CI -7.61 to 32.09 for the right side; MD 11.25, 95% CI -14.10 to 36.60 for the left side; 21 participants, 1 study; very low-certainty evidence). We are uncertain if there is an increase in heel lifts (n) (baseline to six-month changes) between groups (MD 7.70, 95% CI 0.94 to 14.46; 39 participants, 1 study; very low-certainty evidence). There was no clear difference between groups in ankle mobility measured during dynamometry (baseline to six-month change MD -1.40 degrees, 95% CI -4.77 to 1.97; 29 participants, 1 study; very low-certainty evidence). We are uncertain if exercise increases plantar flexion measured by a goniometer (baseline to eight-week change MD 12.13 degrees, 95% CI 8.28 to 15.98 for right leg; MD 10.95 degrees, 95% CI 7.93 to 13.97 for left leg; 21 participants, 1 study; very low-certainty evidence). In all cases, we downgraded the certainty of evidence due to risk of bias and imprecision. AUTHORS' CONCLUSIONS: There is currently insufficient evidence to assess the benefits and harms of physical exercise in people with chronic venous disease. Future research into the effect of physical exercise should consider types of exercise protocols (intensity, frequency, and time), sample size, blinding, and homogeneity according to the severity of disease.

Assuntos

RESUMO

The research in sustainable development goals (SDG) increases year by year since its approval in 2015. Typically, after a phase of exponential growth, the number of publications increases at lower rates, suggesting a consolidation process in which literature reviews become a relevant and high-evidence type of document. In this context, the aim of this study was to perform an unprecedented bibliometric analysis of literature reviews on SDG to assess the evolution and consolidation of the scientific research. Article reviews on SDG from 2015 to 2022 were retrieved from Web of Science core collection and a descriptive bibliometric analysis was performed by growth rate, research area, source, citation, and region. Mapping and cluster analysis using keyword co-occurrence, co-authorship, and bibliographic coupling were also applied. The result revealed that SDG is a fast-growing field, with a trend in the diversification of research areas. Most of the review documents were categorized in general aspects of sustainability. Technology (SDG 9) and economic growth (SDG 8) were spotted as hidden key research areas. This result is contrary to previous bibliometric studies on SDG, demonstrating the rapid evolution and change in the field. In addition, literature reviews on reduced inequalities (SDG 10), gender equality (SDG 5); oceans, seas, and marine environments (SDG 14); and peace, justice, and strong institutions (SDG 16) were revealed as research gaps. Thus, the results demonstrated that the research on SDG cannot yet be considered a consolidated area of research, as it leaves many SDG unexplored. Future research has been proposed accordingly.

Assuntos

RESUMO

OBJECTIVES: To determine the comparative efficacy and safety of a fixed dose of benznidazole (BZN) with an adjusted-dose for Trypanosoma cruzi-seropositive adults without cardiomyopathy. METHODS: We conducted a systematic review and individual participant data (IPD) meta-analysis following Cochrane methods, and the PRISMA-IPD statement for reporting. Randomised controlled trials (RCTs) allocating participants to fixed or adjusted doses of BZN for T. cruzi-seropositive adults without cardiomyopathy were included. We searched (December 2021) Cochrane, MEDLINE, EMBASE, LILACS and trial registries and contacted Chagas experts. Selection, data extraction, risk of bias assessment using the Cochrane tool, and a GRADE summary of finding tables were performed independently by pairs of reviewers. We conducted a random-effects IPD meta-analysis using the one-stage strategy, or, if that was impossible, the two-stage strategy. RESULTS: Five RCTs (1198 patients) were included, none directly comparing fixed with adjusted doses of BZN. Compared to placebo, BZN therapy was strongly associated with negative qPCR and sustainable parasitological clearance regardless of the type of dose and subgroup analysed. For negative qPCR, the fixed/adjusted rate of odds ratios (RORF/A ) was 8.83 (95% CI 1.02-76.48); for sustained parasitological clearance, it was 4.60 (95% CI 0.40-52.51), probably indicating at least non-inferior effect of fixed doses, with no statistically significant interactions by scheme for global and most subgroup estimations. The RORF/A for treatment interruption due to adverse events was 0.44 (95% CI 0.14-1.38), probably indicating no worse tolerance of fixed doses. CONCLUSIONS: We found no direct comparison between fixed and adjusted doses of BZN. However, fixed doses versus placebo are probably not inferior to weight-adjusted doses of BZN versus placebo in terms of parasitological efficacy and safety. Network IPD meta-analysis, through indirect comparisons, may well provide the best possible answers in the near future. REGISTRATION: The study protocol was registered in PROSPERO (CRD42019120905).

Assuntos

RESUMO

Este produto objetiva construir bases de conhecimento sobre o que é necessário para utilizar, com segurança e qualidade, as melhores evidências científicas disponíveis para a tomada de decisão, seja no cotidiano dos processos de trabalho, seja estrategicamente nas políticas e programas de saúde. Propomos reflexões sobre quais dos conceitos operacionais e das melhores práticas adotadas seriam úteis para aplicar no cotidiano de trabalho, entre equipe e instituição. Para isso, apresentaremos os melhores processos de transformação do conhecimento em prática, testados e validados internacionalmente.

This product aims to build a knowledge base on what is needed to safely and qualitatively use the best scientific evidence available for decision-making, both in day-to-day work processes and strategically in health policies and programs. We propose reflections on which of the operational concepts and best practices adopted would be useful to apply in day-to-day work, between the team and the institution. To this end, we will present the best processes for transforming knowledge into practice, which have been tested and validated internationally.

Assuntos

RESUMO

Introdução: A fisioterapia atua na reabilitação de pacientes com amputação transtibial, como também pode intervir na prevenção e tratamento das complicações decorrentes da amputação. Objetivo: Investigar a intervenção da fisioterapia em pacientes com amputação transtibial. Métodos: Foi realizada uma revisão sistemática da literatura, consultando as bases de dados: PubMed, CINAHL, EMBASE, SPORTDiscus, PEDro, LILACS e SciELO. Utilizaram-se os descritores "amputação" e "transtibial" combinados com os descritores "fisioterapia" ou "terapia física". A busca foi realizada na segunda quinzena de fevereiro de 2013. Foram incluídos ensaios clínicos controlados e randomizados, sem restrição de idioma ou período de publicação, que versavam sobre a intervenção fisioterapêutica em pacientes com amputação transtibial. Para avaliação da qualidade metodológica dos estudos foram utilizadas a Escala de Qualidade de Jadad e a Escala PEDro. Resultados: Pela estratégia de busca retornaram 23 artigos, dos quais três foram incluídos na revisão. Um utilizou a técnica de aprendizagem sem erros para a colocação da prótese, outro investigou os efeitos de um programa de treinamento de força e o terceiro comparou os efeitos da aplicação da bandagem convencional e a fisioterapia descongestiva na redução do edema no pós-operatório. Somente um estudo foi considerado de alta ou boa qualidade metodológica pelas Escala PEDro e Jadad, os outros dois estudos foram classificados de baixa qualidade metodológica pelas duas escalas. Conclusões: Observou-se evidência limitada para as modalidades de fisioterapia utilizadas.

Introduction: Physical therapy contributes to the rehabilitation of persons following a transtibial amputation, but may also intervene in prevention and complications treatment. Objective: To investigate the physical therapy intervention in persons following a transtibial amputation. Methods: A systematic review of the PubMed, CINAHL, EMBASE, SPORTDiscus, PEDro, LILACS and SciELO databases was performed. The keywords "amputation" and "transtibial" were combined with the keywords "physiotherapy" or "physical therapy". The search was conducted in February 2013 without language restrictions. We included randomized controlled trials that focused on physical therapy intervention in persons following a transtibial amputation. The Jadad score and the PEDro score were used to assess the methodological quality. Results: Twenty-three studies were obtained from the search. Three were included in the review. One used errorless learning to fit a prosthetic limb, another investigated the effects of a strength training program, and the third study compared the conventional banding and decongestive physiotherapy to reduce edema postoperatively. Only one was considered of high or good methodological quality by Jadad and PEDro scales. The other two studies were rated low methodological quality by two scales. Conclusion: There was limited evidence for physiotherapy modalities used.

Assuntos